OOIR: Observatory of International Research

Papers

(The TQCC of Clinical Gastroenterology and Hepatology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Editorial Board	478
Front Cover	329
Hepatic Artery Pseudoaneurysm After Whipple Procedure	262
Table of Contents	255
Blue Notes	204
Fecal Microbiota Transplantation (FMT) in Ulcerative Colitis: Holding Out for a Superdonor?	200
Reply	197
Perianal Disease in Pediatric-onset Crohn’s Disease: Incidence, Disease Course, and Long-term Outcomes	182
FODMAPs in IBS: Revisiting Restriction	180
Blue Notes	179
Effect of Five Dietary Emulsifiers on Inflammation, Permeability, and the Gut Microbiome: A Placebo-controlled Randomized Trial	170
Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study	162
Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome	161
AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary	160
Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study	159
Editorial Board	155
Disaggregating Racial and Ethnic Data: A Step Toward Diversity, Equity, and Inclusion	144
Development of a Simple, Point-of-Care Device to Test Anorectal Function in Patients with Constipation: Randomized Clinical Trial	139
Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average-Risk Population?	138
High Hospitalization Rates and Risk Factors Among Frail Patients With Cirrhosis: A 10-year Population-based Cohort Study	133
Elsewhere in the AGA Journals	128
Australasian Insights and Perspectives on the Burden of Chronic Liver Disease	126
Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant Disability	125
Association of Statin Usage and the Development of Diabetes Mellitus after Acute Pancreatitis	122
Reply	121

A Case of Pedunculated Esophageal Neuroendocrine Tumor G1	118
Endoscopic Polypectomy: How Should We Determine Complete Resection Status?	116
HBV RNA, Hepatitis B Core-Related Antigen, and Quantitative Hepatitis B Surface Antigen Biomarkers to Predict Outcome of Antiviral Therapy	115
An International Multicenter Comparison of IBD-Related Disability and Validation of the IBDDI	114
Correction	111
Reply	107
The Evolving Landscape of Colorectal Cancer Screening and Colonoscopy Practice: Insights From the Japan Polyp Study	106
Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials	106
Gut Microbiome Modulation by Antibiotics in Adult Asthma: A Human Proof-of-Concept Intervention Trial	102
Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants	102
Elsewhere in the AGA Journals	102
Overall and Annual Postcolonoscopy Colorectal Cancer Rates in a Large Integrated Healthcare Setting: A Cross-Sectional Study	102
Aseptic Abscess Syndrome With Ulcerative Colitis and Pyoderma Gangrenosum	100
Attribution of Colonoscopy Risk Does Not FIT!	100
Issue Highlights	99
Natural History of Patients Lost to Follow-up After Esophageal Food Impaction	99
Reply	98
Nonalcoholic Fatty Liver Disease Natural History: Role of Mathematical Modeling	97
Editorial Board	97
Predictors of Placebo Induction Response and Remission in Ulcerative Colitis	97
Effects of Tenofovir vs Entecavir on Risk of Hepatocellular Carcinoma in Patients With CHB: A Comment for Moving Forward	94
Look for a Physical Health Status Surrogate in Hepatocellular Carcinoma: Have we Found the Holy Grail?	94
Associations Between Sexual Orientation and Disorders of Gut-brain Interaction in Sexual Minority Populations	91
Relative Cost-effectiveness of Management Strategies for Uninvestigated Dyspepsia	91
Trends in Etiology-based Mortality From Chronic Liver Disease Before and During COVID-19 Pandemic in the United States	91
Health Disparities in Inflammatory Bowel Disease Care Driven by Rural Versus Urban Residence: Challenges and Potential Solutions	91
A Novel, Noninvasive Method to Diagnose Active Eosinophilic Esophagitis, Combining Clinical Data and Oral Cavity RNA Levels	90
Genetic Diagnosis Guides Treatment of Autoimmune Enteropathy	90
National Trends and Waitlist Outcomes of Locoregional Therapy Among Liver Transplant Candidates With Hepatocellular Carcinoma in the United States	88
Assessment and Significance of Histologic Activity in Crohn’s Disease	87
Fecal Microbiota-based Therapies Compared to Fecal Microbiota Transplantation for Preventing Recurrent C. difficile Infection	86
Daily or Twice Daily Treatment With Topical Steroids Results in Similar Responses in Eosinophilic Esophagitis	81
AI-Assisted Capsule Endoscopy for Detection of Ulcers and Erosions in Crohn’s Disease: A Multicenter Validation Study	81
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease	78
Barrett’s Esophagus Risk Factors in Patients Without Gastroesophageal Reflux: A Large Population-Based Study	77
Chronic kidney disease does not influence response to terlipressin in hepatorenal syndrome – acute kidney injury	77
Relationship Between Gastric Emptying Rate and Simultaneously Assessed Symptoms in Functional Dyspepsia	76
PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission	76
AGA Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett’s Esophagus: Expert Review	76
Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis	75
Low Daily Step Count Is Associated With a High Risk of Hospital Admission and Death in Community-Dwelling Patients With Cirrhosis	74
Long-term Effectiveness and Safety of Risankizumab in Patients With Crohn’s Disease	74
An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States	74
Who Examines the Colon Matters More Than What Is Removed	73
Low Incidence of Pulmonary Aspiration During Upper Endoscopy in Patients Prescribed a Glucagon-Like Peptide 1 Receptor Agonist	72
The Diagnostic Performance of Fecal Immunochemical Tests for Detecting Advanced Neoplasia at Surveillance Colonoscopy	72
Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population	71
Comparative Efficacy of Biologics and Small Molecule in Ulcerative Colitis: A Systematic Review and Network Meta-analysis	71
Metabolic Signatures of Healthy Lifestyle Patterns and Colorectal Cancer Risk in a European Cohort	71
Update in the Treatment of the Complications of Cirrhosis	71

Functional Gastrointestinal Disorders and Associated Health Impairment in Individuals with Celiac Disease	70
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA	70
Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study	69
Sugar-Sweetened Beverage, Diet Soda, and Nonalcoholic Fatty Liver Disease Over 6 Years: The Framingham Heart Study	69
The Impact of the Social Determinants of Health on Disparities in Inflammatory Bowel Disease	69
Endoscopic Sleeve Gastroplasty Plus Lifestyle Intervention in Patients With Metabolic Dysfunction-associated Steatohepatitis: A Multicenter, Sham-controlled, Randomized Trial	68
Effectiveness of Reinduction and/or Dose Escalation of Ustekinumab in Crohn’s Disease: A Systematic Review and Meta-analysis	68
Extended Risankizumab Treatment in Patients With Crohn’s Disease Who Did Not Achieve Clinical Response to Induction Treatment	67
Table of Contents	67
Blue Notes	66
Reply	66
Front Cover	66
Editorial Board	66
Continuing the Commitment to Diversity, Equity, and Inclusion Within AGA Journals	65
Personalized (N-of-1) Clinical Trials for Inflammatory Bowel Disease: Opportunities and Challenges	65
Acute-onset Type 1 Diabetes Mellitus and Pancreatic Atrophy Caused by an Immune Checkpoint Inhibitor	65
Harm-to-Benefit Ratio of Fecal Immunochemical Test–Based Screening for Colorectal Cancer Given Prior Fecal Hemoglobin Concentrations	64
Risk of Advanced Colorectal Neoplasia at Follow-up Colonoscopy After Synchronous Adenoma and Clinically Significant Serrated Polyp	62
Response to “Recent Advancements and Future Perspectives of Per Oral Endoscopic Myotomy”	62
The Affordable Care Act Improves Access, Survival, and Racial Disparities of Patients With Liver Disease: A Systematic Review	62
Bouveret Syndrome Treated With Endoscopic Lithotripsy and Gallbladder Access via Cholecysto-duodenal Fistula	62
Needle Track Seeding After Trans-gastric EUS-guided Tissue Sampling: Maybe Not as Rare as You Think	61
Reply	61
Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps	61
Reply	60
An Unusual Complication of Endoscopic Ultrasound-guided Transgastric Liver Biopsy	60
Environmental Toxins in Breast Milk and Risk of Early Onset Colorectal Cancer	60
Gastroparesis and Chronic Pancreatitis: Are They Truly Related?	60
Distinct Clinical Physiologic Phenotypes of Patients With Laryngeal Symptoms Referred for Reflux Evaluation	59
Multiple Negative Fecal Immunochemical Tests: Is Testing Really Better?	59
Real-World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn’s Disease	59
The Severity of Reduced Esophageal Distensibility Parallels Eosinophilic Esophagitis Disease Duration	59
Two vs One Forward View Examination of Right Colon on Adenoma Detection: An International Multicenter Randomized Trial	58
Preoperative Hepatology and Primary Care Visits Improve Postoperative Outcomes in Patients With Cirrhosis Undergoing Surgery	58
Perianal Fistulizing Crohn’s Disease–Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus	57
Direct Oral Anticoagulants in Budd-Chiari Syndrome: Need a Closer Look!	57
Value of Ammonia Testing in Clinical Practice	57
Distinctive Clinical Correlates of Small Intestinal Bacterial Overgrowth with Methanogens	57
Health Policy Priorities for the Biden Administration	57
The New Kids on the Block: Emerging Complementary Colonoscopy Quality Metrics	56
Unusual Presentation of a Crohn’s Disease Patient: Not Your Typical Flare	56
Uptake of Colorectal Cancer Screening in 45 to 49 Year Olds: An Early-Inning View from the Endoscopy Suite	56
The Role of Resilience in Irritable Bowel Syndrome, Other Chronic Gastrointestinal Conditions, and the General Population	56
Editorial Board	56
Von Willebrand Factor Level Indicate Response to β-Blockers in Cirrhosis: Need a Closer Look!	55
Reply	55
Information for Authors and Readers	55
Editorial Board	54
Reply	54
Cover	53
Transient Uterine Prolapse: A Rare Complication of Endoscopic Polypectomy	53
Reply	53
Reply	53
Foaming at the Varix: Sclerotherapy of Esophageal Varices via Intrahepatic Portal Vein Access	52
Cover	52
A Framework for Creating a FOAMed Organization in Gastroenterology: Lessons Learned from the Liver Fellow Network	52
Correction	52
Editorial Board	51
Table of Contents	51
Statins for Chronic Liver Disease and the Need for Randomized Controlled Trials	51
Hurdles in ERCP Trials: Do We Need to Change the Diagnostic Criteria for Post-ERCP Pancreatitis?	51
Prior Authorizations Delay Therapy, Impact Decision-making, and Lead to Adverse Events in Inflammatory Bowel Disease: 2022 Provider Survey	51
Close Observation of the Lateral Walls of the Oropharynx During Esophagogastroduodenoscopy	51
Reply	51
Diet and Microbiome-Directed Therapy 2.0 for IBD	50
Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients With Unresectable Hepatocellular Carcinoma	50
Extraintestinal Symptoms in Irritable Bowel Syndrome Are Associated With Stress Reactivity and the Gut Microbiome in a Sex-dependent Manner	50
Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals	50
Deficits in Geriatric Assessment Associate With Disease Activity and Burden in Older Patients With Inflammatory Bowel Disease	49
Upadacitinib in Mothers With Inflammatory Bowel Disease: Placental Transfer and Breast Milk Excretion	49
Diverticulosis Is Associated With Internal Hemorrhoids on Colonoscopy: Possible Clues to Etiology	49
Continuous Risk Score Predicts Waitlist and Post-transplant Outcomes in Hepatocellular Carcinoma Despite Exception Changes	49
Primary Sclerosing Cholangitis–Associated Pouchitis: A Distinct Clinical Phenotype	49
Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn’s Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies	48
Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion	48
Risk of Cancer in Biopsy-Proven Alcohol-Related Liver Disease: A Population-Based Cohort Study of 3410 Persons	48
Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease	48
The EXTENT Study: Results From an International Expert Delphi Consensus to Define Ultrasonographic Parameters for Measuring Bowel Damage in Crohn’s Disease	48
Long-Term Proton Pump Inhibitor Use: Review of Indications and Special Considerations	48
Significance of Crypt Atypia in Barrett’s Esophagus: A Clinical, Molecular, and Outcome Study	48

Real-world Comparison of Steatosis-Associated Fibrosis Estimator and Fibrosis-4 Scores for Assessing Metabolic Dysfunction-associated Steatotic Liver Disease-related Fibrosis in a Highly Diverse Urban	47
Nonrecurrence Rate of Underwater EMR for ≤20-mm Nonampullary Duodenal Adenomas: A Multicenter Prospective Study (D-UEMR Study)	47
Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk After Colorectal Polypectomy	47
All-cause and Cause-specific Mortality in Achalasia: A Nationwide Matched Cohort Study	47
Clinical Outcomes of Intraductal Papillary Mucinous Neoplasms With Dilatation of the Main Pancreatic Duct	47
Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis	47
Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis	46
Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel Syndrome	46
Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn’s Disease	46
Constrictive and Hypertrophic Strictures in Ileal Crohn’s Disease	46
A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis	46
Birth Cohort Colorectal Cancer (CRC): Implications for Research and Practice	46
Colon Volume by Computed Tomography and Scintigraphic Colonic Transit in Constipated Patients With or Without Redundant Colon	46
North American Expert Consensus on the Post-procedural Care of Patients After Per-oral Endoscopic Myotomy Using a Delphi Process	46
Population-based Screening for Hereditary Colorectal Cancer Variants in Japan	45
Skills or Pills: Randomized Trial Comparing Hypnotherapy to Medical Treatment in Children With Functional Nausea	45
Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults	45
Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis	45
Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With Fibrosis	45
Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) Network	45
Prolonged Gastrointestinal Manifestations After Recovery From COVID-19	44
Exploring the Early Phase of Crohn’s Disease	44
Editorial Board	44
Reply	44
Mental health diseases are associated with active hepatitis C and partly drive HCC trends in Veterans	44
Reply	44
Front Cover	44
Avoidant Restrictive Food Intake Disorder Prevalent Among Patients With Inflammatory Bowel Disease	44
Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update	44
Editorial Board	44
Porcelain Gallbladder	43
Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma With Varices Using Red Dichromatic Imaging	43
Reply	43
Nature and Nurture in Familial Aggregation of Steatotic Liver Disease	43
Approach to Dietary Restriction in Irritable Bowel Syndrome	43
Reply	43
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States	43
Blue Notes	43
Reply	43
Lymphangioma in a Child Managed With Debulking Surgery	42
To Stop or Not to Stop? Predicting Relapse After Anti-TNF Cessation in Patients With Crohn’s Disease	42
Repeating Ultrasound for Hepatocellular Carcinoma Detection in Case of Inadequate Liver Visualization: A Matter of Expertise	42
Adult-Onset Fontan Circuit Failure: A Rare Cause of Protein-Losing Enteropathy	42
Editorial Board	41
Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era	41
Reply	41
Front Cover	41
Reply	41
Information for Authors and Readers	41
Disparities in Colorectal Cancer Screening Among Asian American Populations and Strategies to Address These Disparities	41
Blue Notes	40
Letter Response to: Hernandez-Rocha C et al, Clin Gastroenterol Hepatol 2024	40
Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease	40
Ustekinumab and Vedolizumab Safety and Clearance in Pregnancy With Inflammatory Bowel Disease: Stop the Disease, Not the Drug!	40
Editorial Board	40
Elsewhere in the AGA Journals	40
Strong Response to SARS-CoV-2 Vaccine Additional Doses Among Patients With Inflammatory Bowel Diseases	40
Crafting a Therapeutic Pyramid for Eosinophilic Esophagitis in the Age of Biologics	39
Elsewhere in the AGA Journals	39
Prevalence of Liver Steatosis and Fibrosis in Adults With Primary Hypobetaliproteinemia: Results From the HYPOCHOL Study	39
Decreasing Case Fatality Rates for Patients With Cirrhosis Infected With SARS-CoV-2: A National COVID Cohort Collaborative Study	39
Preparing the Next Generation of Gastroenterologists to Tackle Climate Change	39
Reply	39
Diffuse Large B-Cell Duodenal Lymphoma Presenting With Obstruction and Pneumatosis	39
Interventional Radiological Management for Budd-Chiari Syndrome: A 10-Year Retrospective, Multicenter Survey on 997 Patients in China	38
AGA Clinical Practice Update on Endoscopic Lifting Agents: Commentary	38
Stratifying Risks of Ileal Pouch Outcomes	38
Prediction of Postoperative Recurrence in Crohn’s Disease: Where Do We Go From Here?	38
Supplementing Dietary Fibers With a Low FODMAP Diet in Irritable Bowel Syndrome: A Randomized Controlled Crossover Trial	38
Reply	38
Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study	38
Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease	37
Serum Leucine-Rich α2 Glycoprotein: A Novel Biomarker For Small Bowel Mucosal Activity in Crohn’s Disease	37
Perceptions, Definitions, and Therapeutic Interventions for Occasional Constipation: A Rome Working Group Consensus Document	37
Declines in Colorectal Cancer Incidence and Mortality Rates Slow Among Older Adults	37
Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis	37
Prevalence of Chronic Liver Disease in Cholangiocarcinoma: A Meta-Analysis	37
The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude	37
Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn’s Disease	37
Psychiatric Comorbidities Are Highly Prevalent in Nonesophageal Eosinophilic Gastrointestinal Diseases	37
Safety and Efficacy of Cold Snare Polypectomy Without Submucosal Injection for Large Sessile Serrated Lesions: A Prospective Study	37
Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance	37
Establishing an Endobariatric Practice: Steps, Challenges, and Considerations Within a Private Practice Model	37
Contemporary Changes in Etiology for Hepatocellular Carcinoma in Liver Transplantation	37
Effect of Exclusion Diets on Symptom Severity and the Gut Microbiota in Patients With Irritable Bowel Syndrome	37
Defining Noninvasive Criteria for Indicating Drug Therapy in Metabolic dysfunction–associated Steatotic Liver Disease in Clinical Practice	37
Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet, and the Gluten-Free Diet	36
Symptom Classes in Decompensated Liver Disease	36
Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat	36
A Randomized Phase II Study of Efmarodocokin Alfa, an interleukin-22 Agonist, Versus Vedolizumab in Patients With Ulcerative Colitis	36
Depression and Anxiety Are Common Among Patients With Cirrhosis	36
Linked-Color Imaging Detects More Colorectal Adenoma and Serrated Lesions: An International Randomized Controlled Trial	36
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis	36
Safety of Vedolizumab and Ustekinumab Compared With Anti-TNF in Pregnant Women With Inflammatory Bowel Disease	36
Defining Radiological Healing in Perianal Fistulizing Crohn’s Disease: a TOpClass Global Expert Delphi Consensus	36